| Item Type | Name |
|
Concept
|
Arrhythmias, Cardiac
|
|
Concept
|
Combined Modality Therapy
|
|
Concept
|
Palliative Care
|
|
Concept
|
Patient Care Team
|
|
Concept
|
Preoperative Care
|
|
Concept
|
Triazines
|
|
Concept
|
Biomarkers, Tumor
|
|
Concept
|
Hematopoietic Stem Cell Transplantation
|
|
Concept
|
Stem Cell Transplantation
|
|
Concept
|
Treatment Outcome
|
|
Concept
|
Transplantation Conditioning
|
|
Concept
|
Tumor Burden
|
|
Concept
|
Triazoles
|
|
Concept
|
High-Throughput Nucleotide Sequencing
|
|
Concept
|
Cord Blood Stem Cell Transplantation
|
|
Concept
|
fms-Like Tyrosine Kinase 3
|
|
Concept
|
Standard of Care
|
|
Concept
|
T-Lymphocytes
|
|
Concept
|
Transplantation, Autologous
|
|
Concept
|
Transplantation, Homologous
|
|
Concept
|
Signal Transduction
|
|
Concept
|
Tumor Suppressor Protein p53
|
|
Academic Article
|
Great expectations? Conditioning with busulfan, melphalan and thiotepa in recurrent Hodgkin lymphoma.
|
|
Academic Article
|
CD34-Selected Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Relapsed, High-Risk Multiple Myeloma.
|
|
Academic Article
|
Review of salvage therapy for biochemically recurrent prostate cancer: the role of imaging and rationale for systemic salvage targeted anti-prostate-specific membrane antigen radioimmunotherapy.
|
|
Academic Article
|
Gain of chromosome 1q portends worse prognosis in multiple myeloma despite novel agent-based induction regimens and autologous transplantation.
|
|
Academic Article
|
Prospective Evaluation of Unrelated Donor Cord Blood and Haploidentical Donor Access Reveals Graft Availability Varies by Patient Ancestry: Practical Implications for Donor Selection.
|
|
Academic Article
|
Intestinal Microbiota and Relapse After Hematopoietic-Cell Transplantation.
|
|
Academic Article
|
Molecular Minimal Residual Disease Testing in Acute Myeloid Leukemia: A Review for the Practicing Clinician.
|
|
Academic Article
|
The Impact of Toxicities on First-Year Outcomes after Ex Vivo CD34+-Selected Allogeneic Hematopoietic Cell Transplantation in Adults with Hematologic Malignancies.
|
|
Academic Article
|
Impact of Toxicity on Survival for Older Adult Patients after CD34+ Selected Allogeneic Hematopoietic Stem Cell Transplantation.
|
|
Academic Article
|
Effects of Late Toxicities on Outcomes in Long-Term Survivors of Ex-Vivo CD34+-Selected Allogeneic Hematopoietic Cell Transplantation.
|
|
Academic Article
|
Results from a multidisciplinary clinic guided by geriatric assessment before stem cell transplantation in older adults.
|
|
Academic Article
|
Dose escalation prophylactic donor lymphocyte infusion after T-cell depleted matched related donor allogeneic hematopoietic cell transplantation is feasible and results in higher donor chimerism, faster immune re-constitution, and prolonged progression-free survival.
|
|
Academic Article
|
Unexpected Toxicities When Nivolumab Was Given as Maintenance Therapy following Allogeneic Stem Cell Transplantation.
|
|
Academic Article
|
Clinical outcomes of IDH2-mutated advanced-phase Ph-negative myeloproliferative neoplasms treated with enasidenib.
|
|
Academic Article
|
Phase I trial of maintenance selinexor after allogeneic hematopoietic stem cell transplantation for patients with acute myeloid leukemia and myelodysplastic syndrome.
|
|
Academic Article
|
COVID-19 infection in hematopoietic cell transplantation: age, time from transplant and steroids matter.
|
|
Academic Article
|
Germ cell tumors and associated hematologic malignancies evolve from a common shared precursor.
|
|
Academic Article
|
Recommendations and outcomes from a geriatric assessment guided multidisciplinary clinic prior to autologous stem cell transplant in older patients.
|
|
Academic Article
|
Bloodless chimeric antigen receptor (CAR) T-cell therapy in Jehovah's Witnesses.
|
|
Academic Article
|
Fractionated Infusion of Hematopoietic Progenitor Cells Does Not Improve Neutrophil Recovery or Survival in Allograft Recipients.
|
|
Academic Article
|
Echocardiographic predictors of new-onset atrial arrhythmias in patients undergoing hematopoietic stem cell transplantation.
|
|
Academic Article
|
Knowing the unknowns in high risk multiple myeloma.
|
|
Academic Article
|
Efficacy and tolerability of a modified pediatric-inspired intensive regimen for acute lymphoblastic leukemia in older adults.
|
|
Academic Article
|
A phase 1 trial utilizing TMI with fludarabine-melphalan in patients with hematologic malignancies undergoing second allo-SCT.
|
|
Academic Article
|
Clinical and molecular response of acute myeloid leukemia harboring non-canonical FLT3 N676K driver mutations to contemporary FLT3 inhibitors.
|
|
Academic Article
|
Allogeneic hematopoietic stem cell transplant outcomes in adults with inherited myeloid malignancies.
|
|
Concept
|
Long Term Adverse Effects
|
|
Concept
|
Transplantation, Haploidentical
|
|
Concept
|
Cell- and Tissue-Based Therapy
|
|
Academic Article
|
Optimization of Metabolic Tumor Volume as a Prognostic Marker in CAR T-Cell Therapy for Aggressive Large B-cell NHL.
|
|
Academic Article
|
Utility or futility? A contemporary approach to allogeneic hematopoietic cell transplantation for TP53-mutated MDS/AML.
|
|
Academic Article
|
Treatment outcomes of venetoclax-combination regimens for relapsed/refractory myeloid malignancies after anti-CD47-directed therapy.
|